Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
Abstract Cancer immunotherapy aims to initiate or amplify immune responses that eliminate cancer cells and create immune memory to prevent relapse. Immune checkpoint inhibitors (ICIs), which target coinhibitory receptors on immune effector cells, such as CTLA-4 and PD-(L)1, have made significant str...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2024-10-01
|
| Collection: | Experimental and Molecular Medicine |
| Accès en ligne: | https://doi.org/10.1038/s12276-024-01317-9 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|